PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Solesence, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Solesence, Inc.'s yearly results (2022–2025), compared with Consumer Defensive companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Cash Locked Ratio: For every $100 of sales, $34 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $18 tied up three years earlier. More money tied up than 92% of Consumer Defensive companies in United States.
  • Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 89% of Consumer Defensive companies in United States.
  • Shareholder Slice Ratio: Share count rose 43% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 87% of Consumer Defensive companies in United States.

Where $100 of sales goes

$97Operating costs$1.5Interest$2.9Net profit

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-1.1×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Lower than 89% of Consumer Defensive companies in United States.

Cash Locked Ratio

$34

For every $100 of sales, $34 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $18 tied up three years earlier.

More money tied up than 92% of Consumer Defensive companies in United States.

Growth quality

Steadiness Ratio

2/3 · 1/3

Sales grew in 2 of the last 3 years; profit grew in 1 of 3.

Less steady than 62% of Consumer Defensive companies in United States.

Growth Efficiency Ratio

$18

Sales grew 66% in 3 years; of every extra $100 of sales, $18 became extra profit.

Higher than 63% of Consumer Defensive companies in United States.

Asset Productivity Ratio

+66% / +49%

In 3 years sales changed by +66% while total assets changed by +49%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

-1.8×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 85% of Consumer Defensive companies in United States.

Cash Cushion Ratio

−38%

Debt, after subtracting cash, equals 38% of its market value (net debt).

Lower than 62% of Consumer Defensive companies in United States.

Tangible Assets Ratio

—

Data incomplete

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

+43%

Share count rose 43% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 87% of Consumer Defensive companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Solesence, Inc. made a loss over the last year. Solesence, Inc. owes $0.72 for every $1 it owns. Net profit fell 58% in the year to Dec 2025.

Compared with Consumer Defensive companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Solesence, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

4.60

The share price is 4.60 times Solesence, Inc.'s book value per share, higher than 81% of Consumer Defensive companies in United States.

Market cap

$61 M

The total market value of all of Solesence, Inc.'s shares at today's price (share price × number of shares), smaller than 78% of Consumer Defensive companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

$13 M

What Solesence, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$0.19

Net worth divided by the number of shares. The share price of $0.86 is 4.6 times this, which is the P/B above.

Return on equity (ROE)

-18.6%

Solesence, Inc. lost 18.6% of its shareholders' money over the last year, lower than 78% of Consumer Defensive companies in United States.

Owes vs Owns

0.72×

Solesence, Inc. owes $0.72 for every $1 it owns (moderate), higher than 67% of Consumer Defensive companies in United States.

Dividend yield

None

Solesence, Inc. does not currently pay a dividend.

Revenue growth

+19%

Revenue rose 19% in the year to Dec 2025, and grew 18% a year on average over 3 years.

Profit growth

-58%

Net profit fell 58% in the year to Dec 2025.

Profit margin

2.9%

Solesence, Inc. keeps $3 of every $100 of revenue as net profit.

Cash quality

-4.8×

Cash from Solesence, Inc.'s business was -4.8× its reported profit in the year to Dec 2025 — the business used cash even though it reported a profit.

Interest cover

1.7×

Solesence, Inc.'s operating profit covered its interest costs 1.7 times in the year to Dec 2025.

Cash vs debt

Net debt

Solesence, Inc. had $23 M more debt than cash (net debt) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Solesence, Inc.: $61 M ÷ $13 M (30 Jun 2026) = 4.6.

What is Solesence, Inc.'s return on equity?

Solesence, Inc. lost 18.6% of its shareholders' money over the last year, lower than 78% of Consumer Defensive companies in United States.

How much does Solesence, Inc. owe compared with what it owns?

Solesence, Inc. owes $0.72 for every $1 it owns (moderate), higher than 67% of Consumer Defensive companies in United States.

Does Solesence, Inc. pay a dividend?

No. Solesence, Inc. does not currently pay a dividend.

Is Solesence, Inc.'s revenue growing?

Revenue rose 19% in the year to Dec 2025, and grew 18% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.